Literature DB >> 12608441

In vitro and in vivo contractile properties of the vastus lateralis muscle in males with COPD.

R Debigaré1, C H Côte, F S Hould, P LeBlanc, F Maltais.   

Abstract

Peripheral muscle weakness is common in chronic obstructive pulmonary disease (COPD) but it is still under debate whether weakness is due to atrophy or contractile dysfunction. In vitro and in vivo contractile properties of the vastus lateralis muscle were studied in 16 patients with stable COPD (forced expiratory volume in one second 39 +/- 16% of predicted, age 67 +/- 4 yrs (mean +/- sD)) and nine sedentary control subjects. Isometric knee extensor strength was measured while mid-thigh muscle cross-sectional area (MTMCSA) was obtained using computed tomography. Muscle strips from the vastus lateralis obtained through open biopsy were rapidly suspended in an oxygenated Krebs-Ringer solution that was maintained at 35 degrees C with a pH of 7.40 to study their contractile properties. The isometric knee extensors strength/MTMCSA ratio was 0.50 +/- 0.08 versus 0.58 +/- 0.06 kg x cm(-2) for COPD and control subjects, respectively. The muscle bundle cross-sectional area (CSA) was 4.6 +/- 2.1 and 4.4 +/- 3.1 mm(-2), the length at which active tension was maximum was 15 +/- 4 and 15 +/- 3 mm, and maximal isometric peak forces normalised for CSA were 4.3 +/- 2.7 and 4.8 +/- 2.6 N x cm(-2) for COPD and control subjects, respectively. The force/frequency relationship tended to be shifted to the right in patients with COPD, meaning that a higher stimulation frequency was necessary to produce the same relative force. Patients with COPD had a lower proportion of type I fibre than controls (26 +/- 12% versus 39 +/- 11%) with reciprocal significant increase in type IIb fibre proportion (20+/-16% versus 8 +/- 4%). The proportion of type IIa fibres was similar between the two groups. These results suggest that the contractile properties of the vastus lateralis are preserved in patients with chronic obstructive pulmonary disease. Therefore, the reduction in the quadriceps strength in patients with chronic obstructive pulmonary disease cannot be explained on the basis of an alteration of the contractile apparatus.

Entities:  

Mesh:

Year:  2003        PMID: 12608441     DOI: 10.1183/09031936.03.00036503

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  16 in total

1.  Cigarette smoke directly impairs skeletal muscle function through capillary regression and altered myofibre calcium kinetics in mice.

Authors:  Leonardo Nogueira; Breanna M Trisko; Frederico L Lima-Rosa; Jason Jackson; Helena Lund-Palau; Masahiro Yamaguchi; Ellen C Breen
Journal:  J Physiol       Date:  2018-06-19       Impact factor: 5.182

2.  Microbiopsies versus Bergström needle for skeletal muscle sampling: impact on maximal mitochondrial respiration rate.

Authors:  M E Isner-Horobeti; A Charton; F Daussin; B Geny; S P Dufour; R Richard
Journal:  Eur J Appl Physiol       Date:  2014-01-22       Impact factor: 3.078

3.  Molecular mechanisms underlying skeletal muscle weakness in human cancer: reduced myosin-actin cross-bridge formation and kinetics.

Authors:  Michael J Toth; Mark S Miller; Damien M Callahan; Andrew P Sweeny; Ivette Nunez; Steven M Grunberg; Hirak Der-Torossian; Marion E Couch; Kim Dittus
Journal:  J Appl Physiol (1985)       Date:  2013-02-14

Review 4.  Muscle dysfunction in chronic obstructive pulmonary disease: update on causes and biological findings.

Authors:  Joaquim Gea; Sergi Pascual; Carme Casadevall; Mauricio Orozco-Levi; Esther Barreiro
Journal:  J Thorac Dis       Date:  2015-10       Impact factor: 2.895

Review 5.  An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease.

Authors:  François Maltais; Marc Decramer; Richard Casaburi; Esther Barreiro; Yan Burelle; Richard Debigaré; P N Richard Dekhuijzen; Frits Franssen; Ghislaine Gayan-Ramirez; Joaquim Gea; Harry R Gosker; Rik Gosselink; Maurice Hayot; Sabah N A Hussain; Wim Janssens; Micheal I Polkey; Josep Roca; Didier Saey; Annemie M W J Schols; Martijn A Spruit; Michael Steiner; Tanja Taivassalo; Thierry Troosters; Ioannis Vogiatzis; Peter D Wagner
Journal:  Am J Respir Crit Care Med       Date:  2014-05-01       Impact factor: 21.405

6.  Oxygen delivery and the restoration of the muscle energetic balance following exercise: implications for delayed muscle recovery in patients with COPD.

Authors:  Gwenael Layec; Corey R Hart; Joel D Trinity; Oh-Sung Kwon; Matthew J Rossman; Ryan M Broxterman; Yann Le Fur; Eun-Kee Jeong; Russell S Richardson
Journal:  Am J Physiol Endocrinol Metab       Date:  2017-03-14       Impact factor: 4.310

Review 7.  Pathobiological mechanisms underlying metabolic syndrome (MetS) in chronic obstructive pulmonary disease (COPD): clinical significance and therapeutic strategies.

Authors:  Stanley M H Chan; Stavros Selemidis; Steven Bozinovski; Ross Vlahos
Journal:  Pharmacol Ther       Date:  2019-02-26       Impact factor: 12.310

8.  Peripheral muscle endurance and the oxidative profile of the quadriceps in patients with COPD.

Authors:  J Allaire; F Maltais; J-F Doyon; M Noël; P LeBlanc; G Carrier; C Simard; J Jobin
Journal:  Thorax       Date:  2004-08       Impact factor: 9.139

Review 9.  Muscle fibre type shifting in the vastus lateralis of patients with COPD is associated with disease severity: a systematic review and meta-analysis.

Authors:  Harry R Gosker; Maurice P Zeegers; Emiel F M Wouters; Annemie M W J Schols
Journal:  Thorax       Date:  2007-05-25       Impact factor: 9.139

Review 10.  Factors contributing to muscle wasting and dysfunction in COPD patients.

Authors:  Rob C I Wüst; Hans Degens
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.